Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
70%
OVERLAP
BY WEIGHT
60
# OF OVERLAPPING
HOLDINGS
XLV
60
HOLDINGS
100%
ALSO IN IXJ
IXJ
114
HOLDINGS
54%
ALSO IN XLV
SECTOR DRIFT (XLV minus IXJ)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in IXJ |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.5% | 8.8% | 8.8% |
|
JOHNSON & JOHNSON | 7.5% | 5.3% | 5.3% |
|
ABBVIE INC | 6.6% | 4.6% | 4.6% |
|
UNITEDHEALTH GROUP INC | 5.8% | 4.0% | 4.0% |
|
ABBOTT LABORATORIES | 4.8% | 3.4% | 3.4% |
XLV Overweight Relative to IXJ
|
ELI LILLY & CO | 3.7% |
|
JOHNSON & JOHNSON | 2.2% |
|
ABBVIE INC | 2.0% |
|
UNITEDHEALTH GROUP INC | 1.7% |
|
ABBOTT LABORATORIES | 1.4% |
|
MERCK & CO. INC. | 1.2% |
|
INTUITIVE SURGICAL INC | 1.2% |
|
BOSTON SCIENTIFIC CORP | 1.0% |
|
THERMO FISHER SCIENTIFIC INC | 0.9% |
|
AMGEN INC | 0.9% |
XLV Underweight Relative to IXJ
 |
ROCHE HOLDING LTD | -3.3% |
|
NOVARTIS AG | -3.3% |
 |
ASTRAZENECA PLC | -3.1% |
 |
NOVO NORDISK A/S-B | -3.1% |
 |
SANOFI-AVENTIS | -1.5% |
|
GSK PLC | -1.1% |
|
ESSILOR INTERNATIONAL | -1.1% |
 |
CSL LIMITED | -1.1% |
|
LONZA GROUP AG-REG | -0.7% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -0.7% |